Patent Assignment
Reel/Frame 030176/0968
Assignment of Assignor's Interest
Recorded: 2013-04-09
Pages: 9
Assignor
ABBOTT LABORATORIES
Executed: 2012-08-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Properties
(72)
Endothelial Cell Proliferation Inhibitor and Method of Use
Patent:
5,854,221 →
Application:
08/763,528 →
Polymorphic and Other Crystalline Forms Cis-Ftc
Fluorenes and Anthracenes That Inhibit P2X3 and P2X2/3 Containing Receptors
Fused Azabicyclic Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
Apparatus and Method for the Preparation of Experiments Using Proteins Contained Within Gels
Antagonists of Melanin Concentrating Hormone Effects on the Melanin Concetrating Hormone Receptor
Preparation of K-252A
Patent:
6,723,844 →
Application:
10/375,413 →
Antibacterial Compounds
Antibacterial Compounds
Thiopyrimidine and Isothiazolopyrimidine Kinase Inhibitors
N-Sulfonylurea Apoptosis Promoters
Alpha-Hydroxy Acid Ester Drug Delivery Compositions and Methods of Use
Application:
10/403,071 →
Publication:
US 2004/0191207
Oxolide Antibacterials
11-Deoxy Azalide Antibacterials
Tricyclic Macrolide Antibacterial Compounds
Autoinjector with Extendable Needle Protector Shroud
Fused Bicyclic Aromatic Compounds That Are Useful in Treating Sexual Dysfunction
Acetamides and Benzamides That Are Useful in Treating Sexual Dysfunction
Pharmaceutical Formulation Comprising a Peptide Angiogenesis Inhibitor
Fused Compounds That Inhibit Vanilloid Subtype 1 (VR1) Receptor
2-Aminoquinolines as Melanin Concentrating Hormone Receptor Antagonists
Cell Line and Uses Thereof
Fused Azabicyclic Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
3-Amino-2-Hydroxyalkanoic Acids and Their Prodrugs
Azabicyclic Compounds Are Central Nervous System Active Agents
Urea Kinase Inhibitors
Sulfonamides Having Antiangiogenic and Anticancer Activity
Amides That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Spirocyclopropyl Amides and Acids and Their Therapeutic Applications
Anti-Infective Agents
Protein-Tyrosine Phosphatase Inhibitors and Uses Thereof
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Process for Preparing 2-Methylpyrrolidine and Specific Enantiomers Thereof
Fused Tri and Tetra-Cyclic Pyrazole Kinase Inhibitors
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
Polymorphic and Other Crystalline Forms of Cis-Ftc
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
Thienopyridones as Ampk Activators for the Treatment of Diabetes and Obesity
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
Process for Preparing Formulations of Lipid-Regulating Drugs
Substituted Thiazoles
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
(1S,5S)-3-(5,6-Dichloro-3-Pyridinyl)-3,6-Diazabicyclo[3.2.0]Heptane
Fused Compounds That Inhibit Vanilloid Subtype 1 (VR1) Receptor
N-Sulfonylurea Apoptosis Promoters
Amides That Inhibit Vanilloid Receptor Subtype 1 (VR1)
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Fused Bicyclic Aromatic Compounds That Are Useful in Treating Sexual Dysfunction
Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Heterocyclic Kinase Inhibitors
Novel Amides Useful for Treating Pain
Fused Bicyclic Aromatic Compounds That Are Useful in Treating Sexual Dysfunction
(1S,5S)-3-(5,6-Dichloro-3-Pyridinyl)-3,6-Diazabicyclo[3.2.0]Heptane
Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an Ugtiai Substrate
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
N-Sulfonylurea Apoptosis Promoters
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
Application:
12/422,434 →
Publication:
US 2010/0261731
Polymorphic and Other Crystalline Forms of Cis-FTC
Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (VR1) Receptor
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
Application:
13/335,253 →
Publication:
US 2012/0108637
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 25, 1997
From: CAO, YIHAI
To: CHILDREN'S MEDICAL CENTER CORPORATION, THE
Reel/Frame 008451/0680 →
Assignment of Assignor's Interest
Mar 25, 1997
From: FOLKMAN, M. JUDAH
To: CHILDREN'S MEDICAL CENTER CORPORATION, THE
Reel/Frame 008451/0677 →
Assignment of Assignor's Interest
Aug 24, 1998
From: O'REILLY, MICHAEL S.
To: CHILDREN'S MEDICAL CENTER CORP., THE
Reel/Frame 010280/0212 →
Assignment of Assignor's Interest
Jul 16, 2002
From: PHARES, KENNETH R.
To: TRIANGLE PHARMACEUTICALS, INC.
Reel/Frame 013090/0560 →
Assignment of Assignor's Interest
Jul 16, 2002
From: LAW, DEVALINA; HU, YUERONG
To: ABBOTT LABORATORIES
Reel/Frame 013090/0569 →
Assignment of Assignor's Interest
Oct 22, 2002
From: LEE, CHIH-HUNG; JIANG, MEIQUN; PERNER, RICHARD J.; GOMTSYAN, ARTHUR
To: ABBOTT LABORATORIES
Reel/Frame 013189/0797 →
Assignment of Assignor's Interest
Jun 19, 2003
From: SHOBANA, NAVAYATH; STRONG, JOHN C.; TUBERGEN, MARK W.; BRIERLEY, RUSSELL A.
To: ABBOTT LABORATORIES
Reel/Frame 013747/0090 →
Assignment of Assignor's Interest
Jul 16, 2003
From: ELMORE, STEVEN W.; PARK, CHEOL-MIN; WANG, XILU
To: ABBOTT LABORATORIES
Reel/Frame 013805/0518 →
Assignment of Assignor's Interest
Jul 25, 2003
From: ANDERSON, DAVID; BEUTEL, BRUCE; COOPER, CURT; DANDLIKER, PETER
To: ABBOTT LABORATORIES
Reel/Frame 013839/0295 →
Assignment of Assignor's Interest
Jul 28, 2003
From: KYM, PHILIP R.; HARTANDI, KRESNA; GAO, JU; PHELAN, KATHLEEN M.
To: ABBOTT LABORATORIES
Reel/Frame 014430/0902 →
Assignment of Assignor's Interest
Aug 5, 2003
From: ANDERSON, DAVID; BEUTEL, BRUCE; BOSSE, TODD D.; CLARK, RICHARD
To: ABOTT LABORATORIES
Reel/Frame 013855/0412 →
Assignment of Assignor's Interest
Aug 22, 2003
From: OLSON, JEFFREY A.; CHIU, MARK L.; PAN, JEFFREY Y.
To: ABBOTT LABORATORIES
Reel/Frame 013901/0073 →
Assignment of Assignor's Interest
Sep 18, 2003
From: MICHAELIDES, MICHAEL R.; CURTIN, MICHAEL L.; DAI, YUJIA; DAVIDSEN, STEVEN K.
To: ABBOTT LABORATORIES
Reel/Frame 013991/0872 →
Assignment of Assignor's Interest
Sep 22, 2003
From: CLARK, RICHARD; DJURIC, STEVAN; MA, ZHENKUN; WANG, SANYI
To: ABBOTT LABORATORIES
Reel/Frame 013995/0390 →
Assignment of Assignor's Interest
Sep 22, 2003
From: FLORJANCIC, ALAN S.; DJURIC, STEVAN; FLORJANCIC, ALAN S.; YONG, HONG
To: ABBOTT LABORATORIES
Reel/Frame 013995/0378 →
Assignment of Assignor's Interest
Sep 30, 2003
From: FATHALLAH, MARWAN A.; GRABENKORT, RICHARD W.
To: ABBOTT LABORATORIES
Reel/Frame 014016/0706 →
Assignment of Assignor's Interest
Oct 6, 2003
From: LIPARI, JOHN M.; LONG, MICHELLE A.
To: ABBOTT LABORATORIES
Reel/Frame 014025/0603 →
Assignment of Assignor's Interest
Nov 14, 2003
From: GU, YU-GUI; MA, ZHENKUN; YONG, HONG
To: ABBOTT LABORATORIES
Reel/Frame 014127/0250 →
Assignment of Assignor's Interest
Jan 22, 2004
From: MICHAELIDES, MICHAEL R.; CURTIN, MICHAEL L.; DAI, YUJIA; DAVIDSEN, STEVEN K.
To: ABBOTT LABORATORIES
Reel/Frame 015368/0487 →
Merger
Jan 27, 2004
From: TRIANGLE PHARMACEUTICALS, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 014287/0567 →
Assignment of Assignor's Interest
Apr 12, 2004
From: COWART, MARLON D.; LATSHAW, STEVEN P.; NELSON, SHERRY L.; STEWART, ANDREW O.
To: ABBOTT LABORATORIES
Reel/Frame 015203/0476 →
Assignment of Assignor's Interest
Nov 4, 2004
From: DAVIDSON, DONALD J.
To: ABBOTT LABORATORIES
Reel/Frame 015341/0200 →
Assignment of Assignor's Interest
Jan 19, 2005
From: LEE, CHIH-HUNG; BAYBURT, EROL K.; DIDOMENICO, STANLEY JR.; DRIZIN, IRENE
To: ABBOTT LABORATORIES
Reel/Frame 015606/0542 →
Assignment of Assignor's Interest
Sep 21, 2005
From: LIPARI, JOHN M.; LONG, MICHELLE A.
To: ABBOTT LABORATORIES
Reel/Frame 016837/0772 →
Executive Order 9424, Confirmatory License
May 13, 2008
From: CHILDREN'S HOSPITAL (BOSTON)
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020940/0348 →